ABILIFY is indicated for:
- Treatment of Schizophrenia in adults and in adolescents 13 to 17 years of age
- Treatment of manic or mixed episodes associated with Bipolar I Disorder in adults and in pediatric patients 10 to 17 years of age
- Use as an add-on treatment to an antidepressant for adults with Major Depressive Disorder who have had an inadequate response to antidepressant therapy
- Treatment of irritability associated with Autistic Disorder in pediatric patients 6 to 17 years of age
- Treatment of Tourette’s Disorder in pediatric patients 6 to 18 years of age
Reviews
There are no reviews yet.